By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kowa Company 

3-4-14 Nihonbashi-Honcho Chuo-ku

Tokyo    103   Japan
Phone: 81-0-3-32797780 Fax: 81-0-3-32415650



Company News
Gentronix Limited Signs First Japanese Contracted Screening Collaboration With Kowa Company 9/5/2012 9:54:22 AM
Kowa Company Announces the Efficacy and Safety of a Novel Phosphodiesterase 3 Inhibitor K-134 for the Treatment of Intermittent Claudication in American Heart Association 2011 11/10/2011 7:59:31 AM
Kowa Company Announces the Efficacy and Safety of a Novel Rho Kinase Inhibitor (K-115) in the Treatment of Glaucoma in Association for Research in Vision & Ophthalmology 2011 5/10/2011 10:25:47 AM
Kowa Company Announces Peretinoin Reduces Recurrence Risk of Hepatocellular Carcinoma after Curative Therapy 9/13/2010 12:49:43 PM
Eli Lilly and Company (LLY), Kowa Company and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement 12/23/2009 8:42:49 AM
Kowa Company: Study Demonstrates LIVALO(R) Is an Efficacious Treatment for Achieving Lipid Goals LIVALO Superior to Simvastatin in Reducing LDL-C When Comparing Starting Doses 10/22/2009 11:06:49 AM
Kowa Company: LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 9/1/2009 10:57:48 AM
Kowa Company Study Demonstrates Efficacy of Pitavastatin in Elderly Patients 6/16/2009 8:38:35 AM
Teva Pharmaceutical Industries Limited (TEVA) (JOBS), Kowa Company to Partner in Generic Pharma Company in Japan; New Company Teva-Kowa Pharma Co. 9/24/2008 7:17:33 AM
Kowa Company Acquires ProEthic Pharmaceuticals, Inc. New Company to be Called Kowa Pharmaceuticals America 8/4/2008 9:25:00 AM